Using mechanical forces to improve cancer cell therapies
Official title: Synthetic Mechano-Transduction For Improved Cell Therapies In Immuno-Oncology
Funded at Yale University · NIH-11056583 · Data updated 2026-11-12
This study is exploring how using mechanical forces can make CAR T-cell therapies work better for fighting cancer, especially in solid tumors, so that patients can have safer and more effective treatment options.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | December 19, 2024 |
| Project end | November 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $195,766 |
| NIH project number | 1R21CA294038-01A1 |
| Project ID | NIH-11056583 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with solid tumors who may benefit from advanced CAR T-cell therapies.
✕Less likely to help
Patients with hematologic malignancies may not receive direct benefits from this research, as it focuses on solid tumors.
What this research studies
This research investigates how mechanical forces can enhance the effectiveness of CAR T-cell therapies, which are designed to target and destroy cancer cells. By engineering T-cells with special sensors that respond to these forces, the researchers aim to improve the specificity and safety of these therapies, particularly for solid tumors. The project involves measuring forces on immune receptors and developing new tools to enhance T-cell activation and function. Patients may benefit from more effective and safer cancer treatments as a result of this innovative approach.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer cancer therapies for patients with solid tumors.
How similar studies have gone: While the use of mechanical forces in immunotherapy is a novel approach, similar strategies have shown promise in enhancing cellular therapies in preliminary studies.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Berro, Julien — Yale University
- Study coordinator: Berro, Julien
Related research
Other NIH-funded projects on the same topics.
-
Aging Well with HIV: Alcohol, Risk Reduction, and Education Center (AWAR3E)
A center at Yale is exploring how aging with HIV interacts with alcohol use to create inflammation and frailty, with the goal of finding biomarkers and potential treatments.
-
Community Health Worker–Led Hypertension Prevention and Control in Nepal
A community health worker–driven approach in Nepal aims to prevent and control high blood pressure among adults by bringing education and care directly to communities and homes.
-
Community health worker-led hypertension prevention and control in Nepal
A community health worker–led program in Nepal aims to help adults prevent and better control high blood pressure through home visits, education, and ongoing support.
-
Adapting a mobile health tool to boost HIV outcomes for older adults with HIV in Ukraine
A mobile health platform called PositiveLinks would be adapted for older adults with HIV in Ukraine to help them stay engaged in care and improve treatment success.
-
Behavioral and neural links between spoken language sounds and written words in young children
This grant studies how young children learn from listening and reading to improve literacy, by looking at how sound patterns transfer to written language.
-
Understanding how autoimmunity causes myasthenia gravis
This project looks at why the immune system attacks the nerve-muscle connection in myasthenia gravis and how different patient groups are affected.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.